Kimberly-ClarkKMBEarnings & Financial Report
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
KMB Q1 FY2026 Key Financial Metrics
Revenue
$4.2B
Gross Profit
$1.5B
Operating Profit
$753.0M
Net Profit
$675.0M
Gross Margin
36.8%
Operating Margin
18.1%
Net Margin
16.2%
YoY Growth
2.7%
EPS
$2.00
Kimberly-Clark Q1 FY2026 Financial Summary
Kimberly-Clark reported revenue of $4.2B (up 2.7% YoY) for Q1 FY2026, with a net profit of $675.0M (up 17.3% YoY) (16.2% margin). Cost of goods sold was $2.6B, operating expenses totaled $781.0M.
Key Financial Metrics
| Total Revenue | $4.2B |
|---|---|
| Net Profit | $675.0M |
| Gross Margin | 36.8% |
| Operating Margin | 18.1% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Kimberly-Clark Q1 FY2026 revenue of $4.2B breaks down across 2 segments, led by NA at $2.7B (63.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| NA | $2.7B | 63.7% |
| IPC | $1.5B | 36.3% |
Kimberly-Clark Annual Revenue by Year
Kimberly-Clark annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.4B).
Kimberly-Clark Quarterly Revenue & Net Profit History
Kimberly-Clark results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $4.2B | +2.7% | $675.0M | 16.2% |
| Q4 FY2025 | $3.3B | -33.2% | $499.0M | 15.1% |
| Q3 FY2025 | $4.2B | -16.2% | $446.0M | 10.7% |
| Q2 FY2025 | $4.2B | -17.2% | $509.0M | 12.2% |
| Q1 FY2025 | $4.8B | -6.0% | $567.0M | 11.7% |
| Q4 FY2024 | $4.9B | -0.8% | $447.0M | 9.1% |
| Q3 FY2024 | $5.0B | -3.5% | $907.0M | 18.3% |
| Q2 FY2024 | $5.0B | -2.0% | $544.0M | 10.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.03B | $4.95B | $4.93B | $4.84B | $4.16B | $4.15B | $3.29B | $4.16B |
| YoY Growth | -2.0% | -3.5% | -0.8% | -6.0% | -17.2% | -16.2% | -33.2% | 2.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.28B | $17.16B | $16.55B | $16.30B | $16.77B | $16.89B | $17.10B | $17.2M |
| Liabilities | $16.14B | $15.88B | $15.71B | $15.20B | $15.50B | $15.56B | $15.60B | $15.3M |
| Equity | $1.14B | $1.28B | $840.0M | $1.10B | $1.27B | $1.33B | $1.50B | $1.9M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $1.02B | $958.0M | $817.0M | $327.0M | $770.0M | $708.0M | $972.0M |